Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -26.94% is 22% above its 5-year average of -34.45%, near the high end of its 5-year range (-52.67%–-18.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.29% above its 12-month average of -34.67%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -26.94%.
RETURN ON INVESTED CAPITAL (ROIC)
-26.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-34.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-34.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+22.29%
CURRENT VS 3Y AVG
+25.57%
CURRENT VS 5Y AVG
+21.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
+19.30%
vs the sector median at left
Climb Bio, Inc.
Market Cap
$636.48M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-34.67%
3Y Avg
-36.20%
5Y Avg
-34.45%
Market Cap
$640.57M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
Market Cap
$643.45M
Return on Invested Capital (ROIC)
-17.48%
TTM Avg
-24.56%
3Y Avg
-18.89%
5Y Avg
-16.21%
Market Cap
$610.07M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$665.40M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$666.36M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$666.95M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
Market Cap
$600.96M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
Market Cap
$597.83M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | $636.48M | -26.94% | -34.67% | -36.20% | -34.45% |
| Aura Biosciences, Inc. (AURA)vs › | $640.57M | -42.02% | -66.01% | -48.82% | -55.42% |
| OmniAb, Inc. (OABI)vs › | $643.45M | -17.48% | -24.56% | -18.89% | -16.21% |
| AngioDynamics, Inc. (ANGO)vs › | $610.07M | -20.75% | -20.15% | -33.64% | -24.57% |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 1.97% | 18.16% | 11.04% | 1.26% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | -44.30% | -32.94% | -36.44% | -31.30% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -73.27% | -60.64% | -63.77% | -62.42% |
| Fulgent Genetics, Inc. (FLGT)vs › | $600.96M | -11.80% | -7.26% | -5.22% | 9.70% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.83M | 58.60% | 17.42% | -47.16% | -23.48% |
| Annexon, Inc. (ANNX)vs › | $679.13M | -101.43% | -70.16% | -61.78% | -52.46% |
ROIC
-26.9%
ROE
-24.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -26.94% |
| 2026-03-31 | -40.44% |
| 2025-12-31 | -42.16% |
| 2025-09-30 | -33.55% |
| 2025-06-30 | -30.26% |
| 2025-03-31 | -52.67% |
| 2024-12-31 | -38.64% |
| 2024-09-30 | -34.84% |
| 2024-06-30 | -31.27% |
| 2024-03-31 | -18.65% |
| 2023-12-31 | -37.42% |
| 2023-09-30 | -40.70% |
| 2023-06-30 | -43.01% |
| 2023-03-31 | -47.32% |
| 2022-12-31 | -35.02% |
| 2022-09-30 | -34.39% |
| 2022-06-30 | -32.93% |
| 2022-03-31 | -26.96% |
| 2021-12-31 | -21.33% |
| 2021-09-30 | -22.69% |
| 2021-06-30 | -32.33% |
| 2021-03-31 | -52.11% |
| 2020-12-31 | -97.02% |
